ESC 365 - Low circulating hepcidin as a measure of iron deficiency in patients with acute and stable heart failure

HFA Premium Access

Low circulating hepcidin as a measure of iron deficiency in patients with acute and stable heart failure

Session: Poster session 3 - Biomarkers

Topic: Prognosis (using biomarkers)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

25 more presentations in this session

Association between in-hospital variation of natriuretic peptides and short term outcomes in patients hospitalised for worsening chronic heart failure (data from FERIC-RO)

Speaker: Doctor I. Cosei (Bucharest, RO)

Comparable prognostic impacts of plasma B-type natriuretic peptide levels among patients with heart failure with preserved, mid-range and reduced left ventricular ejection fraction

Speaker: Mr S. Kasahara (Sendai, JP)

Unbalanced plasma catestatin and norepinephrine predicted adverse outcomes of chronic heart failure

Speaker: Doctor S. Chu (Beijing, CN)

Natriuretic peptides are mainly measured in elderlies, but remain largely underused and sometimes misused: results of big data analysis

Speaker: Mr M. Lescroart (Paris, FR)

Association between NT-proBNP and metabolic status in young healthy adults.

Speaker: Doctor A. Akopyan (Moscow, RU)

Access the full session

Poster session 3 - Biomarkers

Speakers: Doctor I. Cosei, Mr S. Kasahara, Doctor S. Chu, Mr M. Lescroart, Doctor A. Akopyan

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by